Of note, different studies indicate that an excessive percentage of hyperphosphorylated MARCKS is not only prevalent in colorectal cancer but also occurs in hepatocellular carcinoma, lung and breast cancer (Bickeböller et al. 2015; Chen et al. 2015; Yang et al. 2015). The gene discussed is MARCKS; the disease is breast cancer.